Filtered By:
Vaccination: Pneomococcal Vaccine
Countries: Mexico Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 26 results found since Jan 2013.
Using LASSO regression to estimate the population-level impact of pneumococcal conjugate vaccines
Am J Epidemiol. 2023 Mar 17:kwad061. doi: 10.1093/aje/kwad061. Online ahead of print.ABSTRACTThe pneumococcal conjugate vaccines (PCVs) protect against diseases caused by Streptococcus pneumoniae, such as meningitis, bacteremia, and pneumonia. It is challenging to estimate their population-level impact due to the lack of a perfect control population and the subtleness of signals when the endpoint - like all-cause pneumonia - is non-specific. Here we present a new approach to estimate PCVs' impact - using LASSO regression to select variables in a synthetic control model to predict the counterfactual outcome for vaccine impa...
Source: Am J Epidemiol - March 19, 2023 Category: Epidemiology Authors: Anabelle Wong Sarah C Kramer Marco Piccininni Jessica L Rohmann Tobias Kurth Sylvie Escolano Ulrike Grittner Matthieu Domenech de Cell ès Source Type: research
COVID-19 Pneumonia in Fully Vaccinated Adults during the Dominance of the Omicron Sublineages BA.1.1 and BA.2 in Mexico
Conclusions: Our study suggests that, even when fully COVID-19-vaccinated, older adults and those with chronic conditions were at increased risk of pneumonia during the dominance of the Omicron sublineages BA.1.1 and BA.2.PMID:36013594 | PMC:PMC9412276 | DOI:10.3390/medicina58081127
Source: Medicina (Kaunas) - August 26, 2022 Category: Universities & Medical Training Authors: Efr én Murillo-Zamora X óchitl Trujillo Miguel Huerta M ónica Riós-Silva Jos é Guzmán-Esquivel Jaime Alberto Bricio-Barrios Oliver Mendoza-Cano Agustin Lugo-Radillo Source Type: research
